The UCLA CFAR Virology Core Laboratory has provided HIV-related tissue culture and molecular biology support for UCLA researchers since 1991. The Core has served as a resource for studies of HIV pathogenesis and the associated immune dysfunction. Specifically, the Core acts as a focal point for development and application of novel technologies in HIV molecular virologic assessment and as a bridge between basic and clinical studies conducted at UCLA. The Core also provides training to new investigators in HIV biosafety procedures. The overall purpose of the Core is to provide state of the art techniques of molecular virologic assessment as well as traditional cell culture methods to UCLA researchers. By making the assays and facilities of the Virology Core Facility available to all investigators at UCLA who are studying any aspect of HIV infection, we have successfully fostered interactions between scientists in several departments at the UCLA School of Medicine as well as the Schools of Public Health and Dentistry. Specifically, we will: 1. Maintain storage facilities and serum repositories for UCLA investigators. 2. Provide a biosafety level 3 facility for UCLA investigators. 3. Provide training in the procedures required for biosafety level facilities for UCLA investigators. 4. Introduce novel assays for use by UCLA investigators. 5. Promote the use of our assays and facilities by clinical, basic, public health and behavioral investigators.
| Allyn, P R; O'Malley, S M; Ferguson, J et al. (2018) Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection. Int J STD AIDS 29:334-340 |
| Khamaikawin, Wannisa; Shimizu, Saki; Kamata, Masakazu et al. (2018) Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1. Mol Ther Methods Clin Dev 9:23-32 |
| Foo, Suan-Sin; Chen, Weiqiang; Chan, Yen et al. (2018) Biomarkers and immunoprofiles associated with fetal abnormalities of ZIKV-positive pregnancies. JCI Insight 3: |
| Gorbach, Pamina M; Javanbakht, Marjan; Bolan, Robert K (2018) Behavior change following HIV diagnosis: findings from a Cohort of Los Angeles MSM. AIDS Care 30:300-304 |
| Rotheram-Borus, Mary Jane; Davis, Emily; Rezai, Roxana (2018) Stopping the rise of HIV among adolescents globally. Curr Opin Pediatr 30:131-136 |
| Allan-Blitz, Lao-Tzu; Sakona, Ashyln; Wallace, William D et al. (2018) Coxiella burnetii Endocarditis and Meningitis, California, USA, 2017. Emerg Infect Dis 24: |
| Kojima, Noah; Klausner, Jeffrey D (2018) An Update on the Global Epidemiology of Syphilis. Curr Epidemiol Rep 5:24-38 |
| Nakatsuka, Nako; Hasani-Sadrabadi, Mohammad Mahdi; Cheung, Kevin M et al. (2018) Polyserotonin Nanoparticles as Multifunctional Materials for Biomedical Applications. ACS Nano 12:4761-4774 |
| Cisneros, Irma E; Erdenizmenli, Mert; Cunningham, Kathryn A et al. (2018) Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes. Neuropharmacology 135:431-443 |
| Marsden, Matthew D; Wu, Xiaomeng; Navab, Sara M et al. (2018) Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents. Virology 520:83-93 |
Showing the most recent 10 out of 942 publications
